Are you evaluating bone grafts for treating craniofacial bone defects? Consider BMP2 influence on C2C12 cells as a fast way to get information on how the osteoblasts differentiate. Dr Fahimeh Tabatabaei will be presenting her work at the IADR meeting next week in New Orleans, stop by her poster presentation Saturday, March 16 titled Unraveling Osteogenic Differentiation for Biomaterial Evaluation!
iFyber’s Post
More Relevant Posts
-
Thanks to Innovations in Wound Healing and GR Consulting for hosting an informative symposium on three innovative wound technologies. Featuring great talks from: Dr. george koullias: Clinical Experience with Human Keratin Matrix in the Treatment of Venous Leg Ulcers Dr. Jason Spector: Dermisphere™: Harnessing Microstructural Cues in a Collagen Hydrogel to Optimize Vascular Invasion Dr. Gregory Schultz: Treatment with a Novel Chemical Debridement Tool in Diabetic Foot Ulcers #IWH2023
-
-
Unlock the power of Uterine Fibroid Embolization (UFE) with Dr. Daniel Alterman at the Vascular Institute. Discover the benefits and take the first step towards a healthier, pain-free you, WITHOUT HYSTERECTOMY. Schedule your evaluation today. 1-833-4FIBROIDS Daniel M. Alterman, MD, FACS, FSVS, RPVI
-
Exciting developments in weight loss treatment! 🚀 Dr. Ian Neeland from University Hospitals Harrington Heart & Vascular Institute is leading groundbreaking research on GLP-1 agonists like semaglutide, liraglutide, and tirzepatide. Read how his work aims to deepen our understanding of these meds and shape clinical guidelines for heart and vascular care: https://lnkd.in/eDQt-4Fe
-
-
In the new issue, we address one of the most debated topics of the moment, drug-coated balloons, with 5 articles and some editorials in a minifocus that tell you how the field is evolving and may deserve some of your time: - A viewpoint on the treatment of acute coronary syndromes with drug-coated balloons - BIOASCEND-ISR, a randomized trial of the novel biolimus-coated balloon - An original article on predictors of target vessel failure after de novo lesion treatment with drug-coated balloons - Two-year results of sirolimus-coated balloons in the EASTBOURNE study - A pilot study on the treatment of vulnerable plaques with paclitaxel-coated balloons (DEBuT-LRP) https://lnkd.in/dXhCc-cM
-
-
Are CEA values standard across the board? Our study suggests that that’s not the case.. it varies between platforms and institutions.. so a cyst CEA value need not have a universal cut off but rather individual institutionalized cut off based on internal validation! Time to rethink our approach to using a standard CEA cut off value in diagnosing neoplastic mucinous cysts. Vikram Deshpande Jonas Heymann #pancreascytology
-
The Key to Enhanced Regeneration with fidia's High Tissue PRP! Join O… Discover fidia's Innovative Approach to Tissue Regeneration: Step into the world of advanced regenerative medicine with fidia High Tissue PRP. Dive deep into the science of Platelet-Rich Plasma (PRP) and its remarkable ability to stimulate tissue repair and rejuvenation. Witness how this pioneering treatment can redefine aesthetic and medical practices by harnessing the body's own healing potential.
www.linkedin.com
-
This is a webinar you will not want to miss! Register using the registration link below!
Join us for a unique opportunity to hear from both the inventor of BurstDR™ stimulation, Dr. Dirk De ridder, and the primary collaborator for FlexBurst360™ therapy, Dr. Steven Falowski, as they discuss the clinical evidence behind our proprietary BurstDR™ stimulation and the evolution to the next generation of coverage – FlexBurst360™ therapy. Register for our webinar on March 26 at 7:00 p.m. CT here: https://bit.ly/4a0HIpU. Important Safety Info: https://bit.ly/3kEewB7
-
-
One more day to submit your short talk and poster abstracts #EASD2024!
Abstract deadline May 30th! We seek submissions for short talks and poster session at our one-day meeting during the industry session at #EASD2024. Abstracts selected for short talks will receive a travel award. Topics can include how alpha and delta cell dysfunction leads to hypoglycemia and efforts to therapeutically restore the body’s ability to reverse it. More information about the symposium and abstract submission at https://bit.ly/3VdW1CX
-
Skilled Researcher & Innovator | Strategic R&D Leadership | Biomaterials & Tissue Engineering
5moI'm eager to engage in this meeting and demonstrate how iFyber can assist manufacturers in ensuring the safety, efficacy, and quality of their dental materials or oral health care products. #IADR2024